ECHA on Track with Listing SVHCs

(c) Alexander Raths/Shutterstock
(c) Alexander Raths/Shutterstock

The European Chemicals Agency (ECHA), the administration authority for the EU’s REACH chemical legislation, said it is on track to achieve its goal of having all relevant, currently known substances of very high concern (SVHCs) on the Candidate List by 2020. The inclusion of a substance in the Candidate List imposes legal obligations on manufacturers, importers and users.

In its third progress report on the implementation of the SVHC roadmap, which documents progress for the period 2013-2016, the agency said its main focus now is to get more data on other substances of potential concern so that it and member states can judge the hazards and risks they pose. ECHA is currently requesting more information on 540 substances, but noted that identifying substances of potential concern is becoming increasingly difficult because of the lack of information on their hazards and how they are used.

To speed up the process, ECHA and member states have begun to look more at groups of structurally similar chemicals so that conclusions can be drawn on a larger number of substances at the same time.

Since 2013, ECHA said 900 substances of concern have been put forward for further screening, with more than 600 having now been tested. It also noted that best risk management options had been decided for 67 substances of potential concern, with about half of them being listed as SVHCs.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.